1. Home
  2. TMDX vs VVX Comparison

TMDX vs VVX Comparison

Compare TMDX & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • VVX
  • Stock Information
  • Founded
  • TMDX 1998
  • VVX 2014
  • Country
  • TMDX United States
  • VVX United States
  • Employees
  • TMDX N/A
  • VVX N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VVX Diversified Commercial Services
  • Sector
  • TMDX Health Care
  • VVX Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • VVX Nasdaq
  • Market Cap
  • TMDX 2.1B
  • VVX 1.7B
  • IPO Year
  • TMDX 2019
  • VVX 2014
  • Fundamental
  • Price
  • TMDX $57.20
  • VVX $52.91
  • Analyst Decision
  • TMDX Buy
  • VVX Buy
  • Analyst Count
  • TMDX 11
  • VVX 7
  • Target Price
  • TMDX $116.10
  • VVX $66.86
  • AVG Volume (30 Days)
  • TMDX 2.6M
  • VVX 270.1K
  • Earning Date
  • TMDX 02-24-2025
  • VVX 03-04-2025
  • Dividend Yield
  • TMDX N/A
  • VVX N/A
  • EPS Growth
  • TMDX N/A
  • VVX N/A
  • EPS
  • TMDX 0.94
  • VVX 0.28
  • Revenue
  • TMDX $401,090,000.00
  • VVX $4,204,710,000.00
  • Revenue This Year
  • TMDX $81.61
  • VVX $8.55
  • Revenue Next Year
  • TMDX $22.52
  • VVX $4.72
  • P/E Ratio
  • TMDX $61.04
  • VVX $188.14
  • Revenue Growth
  • TMDX 109.09
  • VVX 7.79
  • 52 Week Low
  • TMDX $56.03
  • VVX $37.04
  • 52 Week High
  • TMDX $177.37
  • VVX $69.75
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 35.74
  • VVX 56.00
  • Support Level
  • TMDX $58.40
  • VVX $45.48
  • Resistance Level
  • TMDX $67.80
  • VVX $51.87
  • Average True Range (ATR)
  • TMDX 4.59
  • VVX 1.63
  • MACD
  • TMDX -0.27
  • VVX 1.01
  • Stochastic Oscillator
  • TMDX 4.44
  • VVX 99.87

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

Share on Social Networks: